SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Grant under Deferred Annual Bonus Plan

29 Mar 2019 09:10

RNS Number : 4648U
Forterra plc
29 March 2019
 

29 March 2019

Forterra plc

Grant under Deferred Annual Bonus Plan

Forterra plc (the "Company") announces that, on 29 March 2019, share option awards over ordinary shares of £0.01 each in the capital of the Company were granted to Executive Directors under the Forterra plc Deferred Annual Bonus Plan ("DABP") as follows:

Name of Director

Number of shares over which the award is granted

Stephen Harrison

35,652

Shatish Dasani

25,468

Total

61,120

These awards represent the deferral into ordinary shares of part of the Executive Directors' 2018 bonus entitlements under the rules of the Scheme.

No consideration was paid for the grant of the awards which are structured as nominal cost options at an option exercise price of £0.01 per ordinary share. The number of ordinary shares granted under the award has been calculated using a share price of £2.959 being an average of the closing mid-market share price for the five days commencing on 12 March 2019 being the date of announcing the Company's 2018 results.

The awards will normally vest on 12 March 2022, subject to the participant being an employee of the Company at that time. Once vested, the award shall normally remain exercisable until the day before the tenth anniversary of the date of grant. Further terms and conditions of the DABP are set out in the Annual Report and Accounts.

The above notification is intended to satisfy the Company's obligations under Article 19 of the Market Abuse Regulations.

Enquiries

Forterra plc:

+44 (0) 1604 707 600

Shatish Dasani (CFO)

Ben Guyatt (Company Secretary)

 

FTI Consulting (public relations adviser to Forterra):

 

+44 (0) 20 3727 1340

Richard Mountain

Nick Hasell

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHJLMLTMBMTMFL

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS